ABSTRACT Controversy exists over the role of endomyocardial biopsy in evaluating patients with dilated cardiomyopathy, particularly in detecting myocarditis and in assessing prognosis. Interobserver variability, if high, could explain conflicting reports. To assess this possibility, we submitted biopsy specimens from 16 patients with dilated cardiomyopathy to seven cardiac pathologists. The same slides were independently reviewed by each and assessed for fibrosis, hypertrophy, nuclear changes on a 0 to 3 + scale, mean lymphocyte count per high-power field, and myocarditis. The prevalance of significant fibrosis ranged from 25% to 69%, hypertrophy from 19% to 88%, nuclear changes from 31% to 94%, and abnormal lymphocyte count from 0 to 38%. One or more pathologists diagnosed definite or possible myocarditis in 11 of the 16 patients. Of these 11 patients, three pathologists agreed about three and two pathologists agreed about five. Myocarditis was diagnosed by a single pathologist in three cases. We conclude that interobserver variability is high in interpreting biopsy specimens from patients with dilated cardiomyopathy and that quantitative and standardized methods are needed to increase diagnostic consistency.
reason for such conflicting data. The purpose of our study was to determine the interobserver variability that exists in the assessment of fibrosis, hypertrophy, nuclear changes, lymphocyte count, and diagnosed myocarditis.
Methods
Patients. Between August 1, 1982, to August 1, 1984, 64 endomyocardial biopsies were performed at the University of Illinois Hospital on patients with cardiomyopathy or idiopathic ventricular tachycardia. Pathologic specimens were selected from 16 of these patients for this study because their clinical presentation at the time of endomyocardial biopsy most strongly suggested myocarditis compared with the entire group in general. The patients' clinical characteristics are summarized in table 1 . Eleven men and five women (mean age 43.8 years) were studied. The mean duration of symptoms before biopsy was 527 days; however, nine of the patients had symptoms less than 180 days. The mean ejection fraction was 22.3%. Four patients experienced a viral prodrome, four had a history of heavy alcohol use, and three had a positive gallium scan, a marker of inflammation. 16 Three patients had coronary disease, but it was not severe enough to explain the degree of left ventricular dysfunction.
Procedure. All endomyocardial biopsies were performed under fluoroscopic guidance by percutaneous puncture of the right internal jugular vein; three to four specimens were obtained Histologic evaluation. Seven cardiac pathologists,* highly experienced in the interpretation of endomyocardial biopsy specimens, agreed to participate in this study. The same slides were sent to each pathologist for review and the results were recorded on a standard form.
Each slide was assessed for endocardial, interstitial, and perivascular fibrosis, cellular hypertrophy, and specific nuclear abnormalities, including enlargement, hyperchromaticity, irregularity, and the presence of nucleoli. A scale of 0 to 3 + was used with 0 considered normal, 1 + mildly abnormal, 2 + moderately abnormal, and 3 + severely abnormal. Scores were given for each individual abnormality and total scores were obtained by adding these scores together in each general category. For example, a patient with 1 + interstitial fibrosis, 2 + perivascular fibrosis, and 2 + endocardial fibrosis would have a total fibrosis score of 5 +.
The pathologists were also asked to determine the mean lymphocyte count in 10 high-power fields and to give the minimum and maximum number of lymphocytes found for the 10 fields examined. Finally, they were asked to comment on whether or not myocarditis was found.
Statistical methods. Interobserver variability was assessed by comparisons, between patients, of the coefficients of variation for each variable score. To further assess the influence of the observer on each of the variable scores, analyses of variance were conducted. The effect of observer on each of the variables was determined. Results Table 2 shows the median coefficient of variation for nuclear changes, fibrosis, hypertrophy, and lymphocyte count as graded by the seven pathologists. Good agreement among the pathologists would be indicated by a low median coefficient of variation. However, the lowest median coefficient of variation for the variables tested was 52.6 and the highest was 183.6. An analysis of variance indicated statistically significant interobserver variability for all variables except nuclear irregularity and interstitial fibrosis. The effect of interobserver variability became less pronounced when we divided the same variables into significant vs nonsignificant abnormalities. Significant abnormalities were defined as those in which the individual score was -2 +, or the total score -4 + for fibrosis and -6 + for nuclear changes. A lymphocyte count was considered significant when the mean count was five or more lymphocytes per high-power field or the highest lymphocyte count in any field greater than 10 cells. Table 3 shows the prevalance per 100 patients of significant abnormalities for each variable in the total patient population. It can be seen that the prevalance varied considerably by pathologist. The range for fibrosis was 25% to 69%, for hypertrophy 19% to 88%, for nuclear abnormalities 31% to 94%, and for a high lymphocyte count 0 to 38%. Only nuclear enlargement, irregularity, and cellular hypertrophy showed a statistically significant observer effect by an analysis of variance (p < .05). was used by the individual pathologists and included acute myocarditis, borderline myocarditis, chronic myocarditis, focal myocarditis, myocarditis, and resolving myocarditis. One pathologist believed that patient 3 had inadequate tissue and three pathologists thought that staining was inadequate in patient 13 . Figure 1 is a hematoxylin and eosin-stained slide from patient 7, in whom a diagnosis of definite myocarditis was made by three pathologists; all three agreed that a high lymphocyte count was present. chronic and acute onset and in other clinical situations such as idiopathic ventricular tachycardia is uncertain. Some studies have demonstrated histologically proven myocarditis responsive to immunosuppressive therapy in some patients.9 However, the ability of this technique to detect myocarditis is variable. For example, some centers have reported a high incidence of myocarditis (63%) in patients with idiopathic dilated cardiomyopathy7 while other centers have found the incidence of myocarditis in dilated cardiomyopathy to be very low (2%).' Even when myocarditis is found, the response to treatment with antiinflammatory drugs has also been variable. Although some centers have reported improvements in left ventricular function, others have not.9' 10 Although differences in patient population or immunosuppressive regimens could potentially explain these conflicting results, nonuniform criteria as to what constitutes myocarditis and inconsistencies in the identification of histologic features of myocarditis could also explain these varying results. To test this hypothesis, we asked a panel of cardiac pathologists to independently interpret the same slides in a blinded fashion without knowledge of the patients' clinical characteristics. We also believed it would be important to establish the interobserver variability that occurs when diagnosing other commonly reported findings of patients with dilated cardiomyopathy such as fibrosis, nuclear abnormalities, and hypertrophy. Only in re- ABiopsy showed abnormal lymphocyte count. FIGURE 1. Photomicrograph of a hematoxylin and eosin-stained slide (magnification 500 X) from patient 7; numerous scattered lymphocytes can be seen as well as cellular hypertrophy and nuclear enlargement. cent studies have investigators attempted to quantitatively correlate these abnormalities with prognosis and hemodynamic variables4; this was not attempted in older studies. '5 In addition, most centers performing endomyocardial biopsies do not have the capabilities for quantitative techniques and often report their findings in a qualitative or so-called semiquantitative fashion, as we asked our panel of pathologists to do.
Our results showed considerable interobserver variability for all data measured. This was particularly true for the diagnosis of myocarditis. The wide variability in terminology by the pathologists made our data somewhat difficult to quantify. However, by grouping these terms into three basic categories of definite, questionable, and no myocarditis, strong observer effects were demonstrated. The same observer effect Finally, we attempted to correlate scores for fibrosis, myocarditis, and other histologic findings with the baseline clinical characteristics of the patients such as ejection fraction and duration of disease. Only an inverse relationship between the ejection fraction and severity of fibrosis was noted. Importantly, no correlation was noted for patients with positive gallium scans and findings of myocarditis on cardiac biopsy.
We believe that this study has important implications for delineating the clinical role of endomyocardial biopsy in the evaluation of patients with dilated cardiomyopathy. Clearly, one of the most important questions to be answered when this procedure is performed is whether or not myocarditis is present. Undoubtedly, reports of unexpected myocarditis in a large percentage of patients with dilated cardiomyopathy,7 idiopathic ventricular tachycardia,17 postpartum cardiomyopathy, 1 and familial cardiomyopathy`9 have CIRCULATION encouraged the increased use of this procedure in hopes of finding a potentially treatable cause of heart failure. However, our study indicates that a diagnosis of myocarditis by one observer may not necessarily be in agreement with that of another observer of the same patient. This must be taken into account when interpreting published data, planning treatment modalities for patients with discovered myocarditis on biopsy, and planning clinical trials to assess the effects of immunosuppressive therapy on patients with diagnosed myocarditis.
Recently, a group of cardiac pathologists in Dallas established standard criteria for diagnosis of myocarditis.20 Hopefully, these criteria will be uniformly accepted and will help reduce confusion in the terminology of myocarditis. These criteria may also reduce interobserver variability, but only a follow-up study such as ours using these new criteria would establish this. Certainly, studies using objective criteria such as histochemical techniques to objectively recognize and quantitate inflammatory cells in biopsy material should reduce observer variability. Objective and quantitative data are already available and are being more widely used to measure fibrosis and hypertrophy and have increased our understanding of what these abnormalities mean in terms of cardiac function and prognosis.
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